None listed
Conditions
Brief summary
This retrospective observational study focuses on COPD patients admitted to the critical care unit. Serum magnesium levels recorded on the date of admission were retrieved from the electronic database. The primary hypothesis is that dysmagnesemia is associated with increased mortality. Additionally, the study evaluates the relationship between magnesium levels and the need for mechanical ventilation, the duration of mechanical ventilation, and the length of hospital stay.
Interventions
The relationship between serum magnesium levels and clinical outcomes, including mortality and the need for invasive or non-invasive mechanical ventilation, has yet to be thoroughly investigated specifically in COPD patients admitted to the ICU. This study aims to investigate the impact of serum magnesium levels on mortality and other clinical outcomes—such as mechanical ventilation requirements, ventilation duration, and ICU length of stay—in critically ill patients with COPD, contributing valuable insights into the management of this patient population. Relevant data, including patients’ gender, age, existing co-morbidities, serum magnesium levels on admission, mechanical ventilation status, mortality, and length of stay, will be collected from medical records, with no active participation required from the patients. The observation period will begin on the day of ICU admission and continue until the patient is discharged.
Sponsors
Eligibility
Inclusion criteria
The study includes COPD patients over 18 years admitted to critical care unit between January 2024 and January 2025
Exclusion criteria
Patients who take magnesium supplements are excluded.